+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Akorn Inc - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 36 Pages
  • December 2021
  • GlobalData
  • Akorn Inc
  • ID: 5513956
Akorn Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope


  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Our summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights


Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including oral liquids, otics, ophthalmics, injectables, topicals, inhalants, and nasal sprays. It also offers contract manufacturing services. Akorn caters to physicians, surgery centers, clinics, optometrists, hospitals, long-term care, wholesalers, retail pharmacies, group purchasing organizations and other pharmaceutical companies. The company has manufacturing facilities in India and the US. It operates in the US, Canada, Mauritius, Luxembourg, Switzerland and India. Akorn is headquartered in Lake Forest, Illinois, the US.

Akorn Inc Key Recent Developments


  • May 28, 2021: Prestige to acquire Akorn’s consumer product portfolio for $230m
  • May 10, 2021: Akorn announces two key executive appointments
  • Oct 28, 2020: Akorn announces its new Board of Directors
  • Sep 02, 2020: Akorn receives court approval of sale to lenders
  • Aug 07, 2020: Akorn provides second quarter 2020 results

Reasons to Buy


  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with Our detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Akorn Inc - Key Facts
  • Akorn Inc - Key Employees
  • Akorn Inc - Key Employee Biographies
  • Akorn Inc - Major Products and Services
  • Akorn Inc - History
  • Akorn Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture

Section 2 - Company Analysis
  • Company Overview
  • Akorn Inc - Business Description
  • Akorn Inc - Corporate Strategy
  • Akorn Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Akorn Inc - Strengths
  • Akorn Inc - Weaknesses
  • Akorn Inc - Opportunities
  • Akorn Inc - Threats
  • Akorn Inc - Key Competitors

Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Akorn Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Akorn Inc, Recent Deals Summary

Section 4 - Company’s Recent Developments
  • May 10, 2021: Akorn announces two key executive appointments
  • Oct 28, 2020: Akorn announces its new Board of Directors
  • Sep 02, 2020: Akorn receives court approval of sale to lenders
  • Aug 07, 2020: Akorn provides second quarter 2020 results
  • May 20, 2020: Akorn to use Voluntary Chapter 11 process to position business for long-term success
  • May 11, 2020: Akorn provides first quarter 2020 results
  • Feb 26, 2020: Akorn provides fourth quarter and full year 2019 results

Section 5 - Appendix
  • Methodology
  • About The Publisher
  • Contact The Publisher
  • Disclaimer

List of Tables
  • Akorn Inc, Key Facts
  • Akorn Inc, Key Employees
  • Akorn Inc, Key Employee Biographies
  • Akorn Inc, Major Products and Services
  • Akorn Inc, History
  • Akorn Inc, Other Locations
  • Akorn Inc, Subsidiaries
  • Akorn Inc, Joint Venture
  • Akorn Inc, Key Competitors
  • Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Akorn Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Akorn Inc, Recent Deals Summary

List of Figures
  • Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Akorn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Teva Pharmaceuticals Ltd
  • Pfizer Inc
  • Perrigo Co Plc
  • Novartis International AG
  • Johnson & Johnson
  • Hikma Pharmaceuticals Plc
  • Fresenius Kabi AG
  • Bausch Health Companies Inc
  • Apotex Inc
  • Allergan Ltd